Recap: Eli Lilly Q3 Earnings

Eli Lilly LLY reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:25 AM.

Here's what investors need to know about the announcement.

Earnings

Eli Lilly beat estimated earnings by 3.12%, reporting an EPS of $1.98 versus an estimate of $1.92.

Revenue was up $168.80 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.44 which was followed by a 1.46% drop in the share price the next day.

Here's a look at Eli Lilly's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 1.69 2.13 2.19 1.68
EPS Actual 1.25 2.62 2.49 1.94
Revenue Estimate 6.70B 6.68B 6.90B 5.70B
Revenue Actual 6.49B 7.81B 8.00B 6.77B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Eli Lilly management provided guidance for FY 2022, expecting earnings between $7.7 and $7.85 per share.

To track all earnings releases for Eli Lilly visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

LLY Logo
LLYEli Lilly and Co
$722.76-0.30%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
38.19
Growth
99.78
Quality
88.23
Value
3.48
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...